We are live on ! Find out more
SRTAW

Strata Critical Medical Inc Warrants

Delisted

SRTAW was delisted on the 6th of May, 2026.

12 hedge funds and large institutions have $6.32M invested in Strata Critical Medical Inc Warrants in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

8.9% more ownership

Funds ownership: 0% → 8.9% (+8.9%)

1% more capital invested

Capital invested by funds: $6.25M → $6.32M (+$65K)

0% more funds holding

Funds holding: 12 → 12 (0)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
4
Closed
–
Calls
$1.72M
Puts
–
Net Calls
+$1.72M
Net Calls Change
-$179K

SRTAW Hedge Fund Activity: Q3 2022 in Review

12 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q3 2022, worth a combined $6.32M — up 1% from $6.25M a quarter earlier.

Fund positioning in SRTAW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 4 trimmed.

The largest buyer was LMR Partners, adding an estimated $95.8K. The largest seller was Privium Fund Management, cutting an estimated $33.6K.

  • 12 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $6.32M of Strata Critical Medical Inc Warrants stock for Q3 2022, up 1% quarter-over-quarter.
  • 0 funds opened new Strata Critical Medical Inc Warrants positions in Q3 2022 and 0 closed out.
  • The largest Strata Critical Medical Inc Warrants buyer in Q3 2022 was LMR Partners, an estimated $95.8K added.
  • The largest Strata Critical Medical Inc Warrants seller in Q3 2022 was Privium Fund Management, an estimated $33.6K sold.

Based on aggregated 13F filings for Q3 2022.